Calidi Biotherapeutics Inc (CLDI)
2.085
-0.06
(-3.02%)
USD |
NYAM |
Nov 22, 10:34
Calidi Biotherapeutics Shareholders Equity (Quarterly): -10.28M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -10.28M |
| June 30, 2024 | -11.75M |
| March 31, 2024 | -14.57M |
| December 31, 2023 | -8.235M |
| September 30, 2023 | -1.094M |
| Date | Value |
|---|---|
| June 30, 2023 | -63.71M |
| December 31, 2022 | -50.44M |
| September 30, 2022 | -43.93M |
| December 31, 2021 | -31.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-63.71M
Minimum
Jun 2023
-1.094M
Maximum
Sep 2023
-26.18M
Average
-14.57M
Median
Mar 2024
Shareholders Equity (Quarterly) Benchmarks
| Lumos Pharma Inc | 4.914M |
| Harrow Inc | 57.98M |
| Allurion Technologies Inc | -64.79M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.657M |
| Total Liabilities (Quarterly) | 16.46M |